Avidity Biosciences Inc
NASDAQ:RNA

Watchlist Manager
Avidity Biosciences Inc Logo
Avidity Biosciences Inc
NASDAQ:RNA
Watchlist
Price: 31.47 USD 0.64% Market Closed
Market Cap: 3.8B USD
Have any thoughts about
Avidity Biosciences Inc?
Write Note

Wall Street
Price Targets

RNA Price Targets Summary
Avidity Biosciences Inc

Wall Street analysts forecast RNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RNA is 68.2 USD with a low forecast of 50.5 USD and a high forecast of 100.8 USD.

Lowest
Price Target
50.5 USD
60% Upside
Average
Price Target
68.2 USD
117% Upside
Highest
Price Target
100.8 USD
220% Upside
Avidity Biosciences Inc Competitors:
Price Targets
CVAC
CureVac NV
3% Downside
PAR
Paradigm Biopharmaceuticals Ltd
97% Upside
1801
Innovent Biologics Inc
17% Downside
MAB
Mabion SA
6% Downside
BIOPOR
Bioporto A/S
194% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
37% Upside
ACAD
ACADIA Pharmaceuticals Inc
25% Upside
OCX
OncoCyte Corp
75% Upside

Revenue
Forecast

Revenue Estimate
Avidity Biosciences Inc

For the last 5 years the compound annual growth rate for Avidity Biosciences Inc's revenue is 36%. The projected CAGR for the next 3 years is 212%.

36%
Past Growth
212%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Avidity Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Avidity Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-57%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RNA's stock price target?
Price Target
68.2 USD

According to Wall Street analysts, the average 1-year price target for RNA is 68.2 USD with a low forecast of 50.5 USD and a high forecast of 100.8 USD.

What is Avidity Biosciences Inc's Revenue forecast?
Projected CAGR
212%

For the last 5 years the compound annual growth rate for Avidity Biosciences Inc's revenue is 36%. The projected CAGR for the next 3 years is 212%.

Back to Top